z-logo
Premium
Patterns of response and acquired resistance to the programmed death‐1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma
Author(s) -
Zalaudek Iris,
Corneli Paola,
Veri Sibil,
Fedele Dahlia,
Papa Giovanni,
Conforti Claudio,
Retrosi Chiara,
Vezzoni Roberta,
Fagotti Serena,
Longone Michela,
Farinazzo Eleonora,
Meo Nicola,
Pizzichetta Maria A.
Publication year - 2019
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13107
Subject(s) - medicine , skin cancer , dermatology , cancer

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom